Fundamentals-based quality & risk · not a recommendation
CCAVENUE scores 67/100 (Quality) on the Orion Score — weak business quality (44), strong growth (95), strong balance-sheet safety (83) and cheap valuation (77). A fundamentals-based quality & risk score, not a buy/sell recommendation.
Risk checks
Forensic accounting
Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check
Technical / Momentum
Price Trend
77/100
Technical momentum companion — separate from the fundamentals-based Orion Score.
Unlock with Pro
Upgrade →Q4 FY2026
Revenue & Profit in ₹ Crores
| Quarter | Revenue | Net Profit | OPM | EPS |
|---|---|---|---|---|
| Q4 2026 | ₹2,489.54 | ₹79.38 | 2.8% | ₹0.28 |
| Q3 2026 | ₹2,381.19 | ₹71.88 | 3.2% | ₹0.26 |
| Q2 2026 | ₹1,964.91 | ₹66.52 | 3.9% | ₹0.23 |
| Q1 2026 | ₹1,280.21 | ₹61.25 | 4.2% | ₹0.21 |
| Q4 2025 | ₹1,160.52 | ₹49.1 | 5.2% | ₹0.19 |
Q1 FY2027
No recent corporate actions
Ask: "Is CCAVENUE stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.